Cryoport Systems Wins CPHI Pharma Award for Supply Chain Excellence 

We are proud to announce that Cryoport Systems has been awarded the prestigious Supply Chain Excellence Award at the 2025 CPHI Pharma Awards, a recognition that celebrates innovation, impact, and leadership in pharmaceutical supply chain management. This honor reflects our unwavering commitment to transforming the way life-saving therapies are managed and delivered to patients across the globe.  

Winning this award is a testament to the dedication of our teams, the trust of our clients and partners, and the strength of our integrated platform that continues to set the standard for temperature-sensitive supply chain solutions.  

Innovation With Purpose 

Cryoport Systems was recognized for our integrated end-to-end supply chain platform, a purpose-built solution designed to meet the complex and evolving needs of the biopharmaceutical industry. From early-stage clinical trials to global commercial distribution, our platform delivers transparency and reliability at every step.  

What sets us apart is our ability to unify six critical pillars into one harmonized ecosystem: 

1. Temperature-Controlled Logistics and Shipping Systems supporting cryogenic, ultra-cold, refrigerated, and controlled room temperature shipments with the industry’s largest wholly-owned fleet of shipping systems and our proprietary Cryoshuttle^® service. 
2. Global BioServices Network offering cGMP-compliant biostorage, clinical sample management, drug packaging and labeling, kit production, and other custom services across strategic U.S. and European facilities 
3. Consulting and Advisory Support providing expert guidance on packaging qualification, shipping risk assessment, shipping lane qualification, and risk-based planning to ensure compliance and efficiency in support of regulatory filings 
4. IntegriCell^® Cryopreservation Services standardizing leukapheresis-derived starting material cryopreservation workflows to reduce variability and improve scalability across clinical and commercial programs 
5. Continuous Condition Monitoring leveraging Smartpak™ devices and our Cryoportal^® logistics management system to provide uninterrupted visibility into shipment conditions, enabling proactive risk mitigation and audit-ready records management 
6. Renowned Facility Infrastructure building strategically located facilities that ensure timely, compliant service delivery close to manufacturing and treatment centers  

Together, these pillars form a single-source solution that eliminates fragmentation and reduces risk, empowering biopharmaceutical innovators to focus on what matters most… delivering better outcomes.  

Setting the Standard for Excellence 

With advanced therapies, every shipment represents a life-saving therapy and with this in mind, Cryoport Systems is redefining what it means to be a supply chain partner. Our platform moves materials, yes, but it also protects their integrity and ensures compliance while supporting scalability. Whether enabling a first-in-human clinical trial or supporting a global commercial launch, we deliver peace of mind and industry-leading quality and scalability.   

Our solutions are backed by rigorous compliance standards, including ISO 9001:2015 and ISO 21973, and our experts have contributed to the development of these very standards. This commitment to quality and leadership ensures that our services are performed uniformly across all global locations, delivering the same high level of excellence no matter where our clients operate.  

A Win for Industry and Patients 

This award is not just a recognition of Cryoport Systems, it speaks to the progress being made in cell and gene therapy, biologics, and other next-generation advanced treatments. By solving some of the most pressing challenges in the supply chain like vendor fragmentation, lack of visibility, inconsistent cryopreservation, and risk exposure, we are helping to accelerate innovation and bring therapies to patients faster and more safely.  

We’re honored to be recognized by CPHI and proud to celebrate with and stand alongside other industry leaders who are shaping the future of pharmaceutical development. As we continue to evolve and expand our platform, we remain focused on Enabling the Outcome™ by supporting the safe, compliant delivery of life-saving therapies around the world. 

Thank you to our clients, partners, and world-class team who made this achievement possible. Together, we’re not just winning awards, we’re transforming lives.